Biovie INC 10-K annual reports

BioVie Inc. reports a reduced net loss but faces substantial doubt about its ability to continue as a going concern, grappling with ongoing securities litigation and past clinical trial integrity issues.

BioVie Inc. released its annual 10-K filing, detailing progress in its clinical programs for neurological disorders and liver disease, along with its financial results for the fiscal year ended June 30, 2024.